Why the study?
To characterize 3D echocardiographic changes in mitral valve geometry after third-generation MitraClip XTR implantation according to underlying functional versus degenerative mitral regurgitation mechanisms.
Does MitraClip XTR implantation acutely improve mitral valve geometry and reduce mitral regurgitation in high-risk patients with significant MR?
Does MitraClip XTR implantation acutely improve mitral valve geometry and reduce mitral regurgitation in high-risk patients with significant MR?
MitraClip XTR implantation acutely restores mitral geometry with distinct effects based on MR etiology, and baseline anterior mitral leaflet angle predicts procedural success.
Acute 3D echo reveals mechanism-specific MV remodeling after XTR; leaves open whether these changes predict durable MR reduction or outcomes.
Background Mitral valve (MV) repair with MitraClip system is a safe treatment option for high‐risk patients with significant mitral regurgitation (MR). We aimed to characterize, by three‐dimensional echocardiography (3D‐E), changes occurring in MV after implantation of third generation MitraClip XT R device, with specific reference to the underlying MR mechanism (functional vs degenerative, FMR vs DMR). Methods We prospectively enrolled 59 patients, who underwent intra‐procedural 3D‐E before and after device deployment. Three‐D datasets were analyzed off‐line, using a dedicated semiautomatic software, to obtain parametric quantification of mitral anatomy. Results Post‐procedural MR of mild or lesser degree was achieved in 40 patients (68%), with no differences between FMR and DMR ( p 0.9). After MitraClip XT R implantation, the FMR group experienced an immediate annular resizing, with reduction of antero‐posterior diameter ( p 0.024) and sphericity index ( p 0.017), next to a recovery of physiological saddle‐shape, defined by lower non‐planar angle (p ≤0.001) and higher annulus height to commissural width ratio ( p ≤0.001). On the opposite, the DMR group revealed a significant decrease of maximum annular velocity ( p 0.027), addressing a mechanic effect of the device deployment. Finally, baseline anterior mitral leaflet angle was found as an independent predictor of acute procedural result (OR 6.7, [CI 1.01–44.33], p 0.049). Conclusions MitraClip XT R implantation acts in restoring the original mitral geometry, with distinctive effects according to MR mechanism. Three‐D parametric quantification of MV sheds new light on changes occurring in the valvular apparatus, and helps identifying possible new predictors of acute procedural success.
No takes yet. Share an insight, caveat, or question.
Tusa et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: